Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9

Potent and selective inhibitors of Nav1.7

Substituted 1,3-thiazoles as heat shock transcription factor 1 activators

Promoter compositions

Methods and compositions employing immunogenic fusion proteins

Sensation-improving agent

Methods and compositions for delivering interleukin-1 receptor antagonist

FUSION POLYNUCLEOTIDES AND FUSION POLYPEPTIDES ASSOCIATED WITH CANCER AND PARTICULARLY MELANOMA AND THEIR USES AS THERAPEUTIC AND DIAGNOSTIC TARGETS

Effective generation of tumor-targeted T cells derived from pluripotent stem cells

Methods and compositions for targeting polyubiquitin

Fusion molecules and uses thereof

Chimeric receptors with 4-1BB stimulatory signaling domain

CELL PENETRATING PEPTIDES WHICH BIND IRF5

Process for isolation of plasma or serum proteins

Vault compositions for immunization

KNTC2 peptides and vaccines containing the same

STIP1 polypeptides and uses thereof

Method for inhibiting the SWAP-70 protein

Reagent for diagnosing tumor, pharmaceutical composition, and screening method

BREAST-CANCER DETERMINATION METHOD

Methods and compositions for treating genetically linked diseases of the eye

Nucleic acids encoding FHL1 mutations associated with novel X-linked muscular myopathies and methods of screening a subject

LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS

FUSION PROTEINS AND METHODS FOR IDENTIFYING BROMODOMAIN INHIBITING COMPOUNDS

Artificial bioparticle and method of manufacturing the same

Treating human immunodeficiency virus infections

WHEY PROTEIN CONCENTRATE, ITS PREPARATION AND ITS USE

Regulatory T cell epitopes, compositions and uses thereof

Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis

Dominant negative HSP110 mutant and its use in prognosing and treating cancers

In vivo production of proteins

Method for Inducing Formation of Neurons from Embryonal Stem Cells

Compositions and methods for the delivery of oxygen

Milk-derived basic protein fraction as skin sensitivity improving agent

TMEM120A ion channel modulator

Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof

Modified polynucleotides for the production of secreted proteins

Compositions and methods for the expansion of stem cells

Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion

Cancer antigen EEF2

MG53 Mutant, Methods of Mutation and Use Thereof

Autophagy-inducing peptide analogs

Formulations of guanylate cyclase C agonists and methods of use

PEPTIDES FOR ENHANCING PROTEIN EXPRESSION

Production cell line enhancers

STABILIZED STAT3 DECOY OLIGONUCLEOTIDES AND USES THEREFORE

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

METHOD OF GENETICALLY ALTERING AND PRODUCING ALLERGY FREE CATS

Retinal OFF circuit-specific promoter

Compositions of active Wnt protein

ANTIBODY AGAINST THE PROTEIN TRIO AND ITS METHOD OF PRODUCTION

Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof

Non-Transgene Transfection for Therapeutic Purposes

VARIANT OF BPIFB4 PROTEIN

NEUROTROPHIN-TYROSINE KINASE RECEPTOR SIGNALING

OSTEOPONTIN VARIANTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH AND COMPOSITIONS CONTAINING SUCH OSTEOPONTIN VARIANTS

TNNT1 mini-promoters

RECOMBINANT LUBRICIN MOLECULES AND USES THEREOF

ANIMAL MODEL WITH A FILAGGRIN GENE PROMOTER

Regulatory nucleic acid elements

PLANT CENTROMERE COMPOSITIONS

CCN3 and CCN3 peptides and analogs thereof for therapeutic use

Weight loss by inhibition of gastrokine

CHIMERIC DYSTROPHIN PROTEINS TO TREAT DYSTROPHINOPATHIES

OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT

Mutant NGAL proteins and uses thereof

Method for preparing C1q recombinant protein

Compositions and methods for regulating thermogenesis and muscle inflammation using metrnl and metrn

Lipocalin fusion partners

Curcumin-peptide conjugates and formulations thereof

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen

CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same

Method of producing heterogeneous protein

RNA preparations comprising purified modified RNA for reprogramming cells

Antibody to genetic products differentially expressed in tumors and the use thereof

Immune modulator for immunotherapy and vaccine formulation

Method of inducing an immune response by administering WDRPUH epitope peptides

Prion epitopes and methods of use thereof

Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia

Materials and Methods for Regulating Whole Body Glucose Homeostasis

IDENTIFICATION OF THERMOTOLERANCE GENES IN YEAST

Stresscopins and their Uses

BIOLOGICALLY FORMED NANOSCALE DEVICES

Heterogeneous nuclear ribonucleoprotein A2* (HNRNP A2*) and nucleic acid encoding the same

Medicament for atrophy treatment or increasing cell growth

METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES

THERMO-RESPONSIVE LECTIN-ELP FUSION BINDING LIGANDS FOR GLYCOPROTEIN PURIFICATION BY AFFINITY PRECIPITATION

Process for producing an allergen extract

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TINNITUS

Determining pathological cartilage turnover

Protein expression enhancing polypeptides

Pharmaceutical composition for treatment and/or prevention of gallbladder cancer

Natriuretic polypeptides

AGENT FOR TREATING OR PREVENTING SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

Binding proteins comprising at least two repeat domains against HER2

Polypeptide expressed in the stratum corneum and use thereof

Methods for treating parkinson's disease by optically stimulating target cells

COMPOSITION COMPRISING GRIM-19 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASES

Methods for treating colon cancer and inflammation associated with overexpression of human signal peptide-containing proteins

mTOR ligands and polynucleotides encoding mTOR ligands

HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) MUTEINS THAT BIND HEPCIDIN AND NUCLEIC ACID ENCODING SUCH

Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium

Marker peptide for determining risk of hyperglycemia and use thereof

Synthetic linear apelin mimetics for the treatment of heart failure

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN

Method for crystallization of TRX-TXNIP complex mutein and 3D structure thereof

Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3

Chimeric fibronectin matrix mimetics and uses thereof

Tear lipocalin muteins binding IL-4 R alpha

METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT

Method for the production of polypeptides in the periplasm of prokaryotic cells

Repeat protein from collection of repeat proteins comprising repeat modules

Method for treating spinal cord injury using HMGB1 fragment

Assay for Screening of Anti-Viral Compounds That Inhibit Specific Interaction Interfaces Between Cullin5 and an ElonginB/ElonginC/ CBF-beta/HIV-1 Vif Complex

Anti-C5a binding moieties with high blocking activity

Peptide directed protein knockdown

Compositions and methods for the delivery of nitric oxide

DPP8 and DPP9 peptide inhibitors

Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)

Surgical applications for BMP binding protein

Microtubule-modifying compound

Anti-Glypican 3 Antibody

Peptides for the treatment of neurodegenerative diseases

Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide

MODULATION OF PODOPLANIN MEDIATED PLATELET ACTIVATION

Novel Gene Targets Associated with Amyotrophic Lateral Sclerosis and Methods of Use Thereof

Human anti-tau antibodies

Apolipoprotein AIV as an antidiabetic peptide

Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof

Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis

METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE

Method for the treatment of cardiovascular fibrosis

Antibodies that specifically bind to DRG11-responsive (DRAGON) proteins

Methods and compositions for specific modulation of MCL-1

Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor

Peptides that bind to epithelial cell adhesion molecule

HSP104 variants and uses thereof

Antibodies that specifically bind to DRG11-responsive (DRAGON) proteins

Use of regulatory T cell-specific surface protein LRIG-1

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

Cell-penetrating peptides and uses thereof

Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

Use of PEDF-derived polypeptides for treating osteoarthritis

Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy

Assembly of at least one vegetable protein and at least one dairy protein

Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein

Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging

Peptides and methods for inducing cell death

Charged Nutritive Fragments, Proteins and Methods

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE

Treatment of pain by inhibition of USP5 de-ubiquitinase

WHEY PROTEIN COATED FILMS

NANOCONSTRUCTS WITH PHARMACOLOGICAL ACTIVITY

NOVEL PEPTIDES THAT BIND TO TYPES OF MHC CLASS II AND THEIR USE ON DIAGNOSIS AND TREATMENT

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

Compositions and methods for oxygenation of nucleic acids containing 5-methylpyrimidine

Biocatalysts for Ezetimibe synthesis

Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling

Syndecan peptides and polypeptides as inhibitors of cancer

IMMUNOMODULATORY PROTEINS

Antimicrobial compositions comprising a hyaluronic acid binding peptide and a β-lactam antibiotic

Multivalent and Monovalent Multispecific Complexes and Their Uses

Screening methods for transfusion related acute lung injury (TRALI)

Compounds and methods for modulating pharmacokinetics

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

AAV mediated aquaporin gene transfer to treat Sjogren's syndrome

Method for the preparation of a serum protein concentrate

HMGB1 variants and uses thereof

IgE peptide vaccine

Compositions and methods for brown fat induction and activity using FNDC5

Single-domain antibodies with improved thermal stability under cytoplasmic expression

Methods for introducing mannose 6 phosphate and other oligosaccharides onto glycoproteins and applications thereof

Medicament for wound treatment

Soluble MANF in pancreatic β-cell disorders

Peptides derived from NCAPG2 and their use

Antimicrobial peptides based on CMAP27

Generation of native recombinant secreted human endoplasmic reticulum chaperones by using their native signal sequences in yeast expression systems

VECTORS ENCODING A PARALYTIC PEPTIDE

CDCA1 epitope peptides for Th1 cells and vaccines containing the same

Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof

EML4-ALK fusion gene

HUMAN FUSION PROTEINS COMPRISING SINGLE CHAIN TNFALPHA AND TARGETING DOMAINS

CARDIAC ARRHYTHMIA TREATMENT METHODS

Targeted therapeutics

SH2 domain variants

METHOD FOR IDENTIFYING MARKER SEQUENCES FOR GYNAECOLOGICAL MALIGNANT TUMOURS

Resonance energy transfer assay with cleavage sequence and spacer

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Production cell line enhancers

Composition for preventing or treating fracture or osteoporosis using slit-robo system

Induction of tumor immunity by variants of folate binding protein

REVERSIBLE MASKING OF PORE-FORMING PROTEINS FOR MACROMOLECULAR DELIVERY

MODIFICATION OF THE IMMUNOMODULATORY EFFECTS OF CELLS

Peptide-based collagen modulators for wound healing and tissue repair

Selective cartilage therapy

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

Methods and compositions for treating hemophilia

COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE

Modified polynucleotides for the production of cosmetic proteins and peptides

Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban

Marker peptide for determining risk of developing metabolic syndrome, and use thereof

Engineered cleavage half-domains

Methods and compositions for genome engineering

Methods and Compositions for the Treatment of Immune Disorders

TRANSGENIC PLANTS EXPRESSING COBALAMIN BINDING PROTEINS

LIVESTOCK WITH GENETICALLY MODIFIED PROLACTIN RECEPTOR

Cereblon isoforms and their use as biomarkers for therapeutic treatment

Antibody that binds murine wise protein

Modulation of TLR4-signaling pathway

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

Controlled gene expression methods

Selective PYY compounds and uses thereof

Peptides having activity of inhibiting infections of respiratory viruses and use of the same

Vault complexes for cytokine delivery

BAG3 as biochemical serum and tissue marker

SPECIFIC BIOMARKERS FOR HEPATOCELLULAR CARCINOMA (HCC)

REPLIKIN SEQUENCES AND THEIR ANTIBODIES FOR DIAGNOSTICS, THERAPEUTICS, AND VACCINES AGAINST PRION AND NEURODEGENERATIVE DISORDERS INCLUDING ALZHEIMER'S DISEASE

Non-human animals having a humanized a proliferation-inducing ligand gene

NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE

Transgenic non-human animal comprising a mutant alpha-synuclein

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

ELISpot diagnostic kit for neuromyelitis optica and its application

Compositions and methods for promoting wound healing and tissue regeneration

Compositions which regulate the epithelial brush border Na/H exchanger NHE3 and their methods of use in gastrointestinal disease

Peptide compounds derived from melanotransferrin and uses thereof

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

Biomimetic coating of magnesium alloy for enhanced corrosion resistance and calcium phosphate deposition

Melanoma antigen peptide and uses thereof

Soluble VEGFR-1 variants for diagnosis of preeclampsia

Nuclease-mediated regulation of gene expression

Nutritive Fragments and Proteins with Low or No Phenylalanine and Methods

Mutant alpha-synuclein, and methods using same

Fused cyclooctyne compounds and their use in metal-free click reactions

RTN4B polypeptide, monoclonal antibody thereof, monoclonal antibody-producing hybridoma cell strain, and, preparation and application thereof

SP-B and SP-C peptides, synthetic lung surfactants, and use thereof

Cytokine-based fusion proteins for treatment of immune disorders

Modular nanodevices for smart adaptable vaccines

Nanosphere-histone acetyltransferase (HAT) activator composition, process and methods thereof

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

Modified peptides and their use for treating autoimmune diseases

In vivo production of proteins

hDC-sign binding peptides

Peptide compositions

Compositions and methods for the treatment of VprBP-related cancers

Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein

COMPOSITIONS AND METHODS FOR TREATING PTSD AND RELATED DISEASES

Non-N-glycosylated recombinant human annexin A2

AKT ligands and polynucleotides encoding AKT ligands

Wnt compositions and therapeutic uses of such compositions

Protoxin-II variants and methods of use

C1q/TNF-RELATED PROTEIN-9 (CTRP9) AND USE IN PREVENTION AND TREATMENT OF METABOLIC DISORDERS

Hybridization- independent labeling of repetitive DNA sequence in human chromosomes

Influenza nucleoprotein vaccines

Leucine zipper variant and use thereof

Use of the cathelicidin LL-37 and derivatives thereof for wound healing

Use of immunesuppressant receptor

Vault and vault like carrier molecules

HLA-BINDING PEPTIDES, PRECURSORS THEREOF, DNA FRAGMENTS AND RECOMBINANT VECTORS THAT CODE FOR THOSE PEPTIDE SEQUENCES

Nutritive proteins and methods

IMPORTATION OF MITOCHODRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH

Immunostimulatory oligonucleotides

Anti-sPLA2-IIA antibodies and uses thereof

Nitration shielding peptides and methods of use thereof

Activated Polyoxazolines and Conjugates and Compositions Comprising the Same

Targeted histone acetylation

Modified apelin polypeptides

RNASE 7 ANTIMICROBIAL PEPTIDES

Opsin polypeptides and methods of use thereof

LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same

ANTAGONISTIC PEPTIDES FOR FRIZZLED-1 AND FRIZZLED-2

Efficient non-meiotic allele introgression

Methods of treating cancer having an active Wnt/β-catenin pathway

Sequences associated with TDP-43 proteinopathies and methods of using the same

Modified polynucleotides for the production of proteins

SENSE-IMPROVING AGENT

Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition

COMPOSITIONS FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH ABNORMAL ANGIOGENESIS

NOVEL FUSION GENES IDENTIFIED IN LUNG CANCER

Modulators for Sirt5 and assays for screening same

Bone morphogenic protein binding peptide

Composition and method for diagnosis and immunotherapy of lung cancer

Protein layers and their use in electron microscopy

COMBINATORIAL DNA LIBRARY FOR PRODUCING MODIFIED N-GLYCANS IN LOWER EUKARYOTES

Antibodies that specifically bind to DRG11-responsive (dragon) proteins

Antibodies that specifically bind to DRG11-responsive (dragon) proteins

CELLULOSE-/CHITIN-TYPE POLYMERIC LIGHT-EMITTING MATERIAL

Fibronectin binding domains with reduced immunogenicity

Reagents And Methods for Detecting Protein Lysine 3-Hydroxybutyrylation

Manufacture of inter-alpha-inhibitor (IaIp) from plasma

IDENTIFICATION OF A NOVEL BHD GENE

Bone substitute nanocomposites and methods of synthesis using multiphosphorylated peptides

Monoclonal antibodies and diagnostic uses thereof

Development and use of fluorescent probes of unbound bilirubin

RNA containing modified nucleosides and methods of use thereof

Method to overcome DNA chemical modifications sensitivity of engineered tale DNA binding domains

ARRDC1-mediated microvesicles (ARMMs) and uses thereof

Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammation

ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2